Skip to main content
Sinopharm Group Co. Ltd. logo

Sinopharm Group Co. Ltd. — Investor Relations & Filings

Ticker · 1099 ISIN · CNE100000FN7 LEI · 529900N54X78YH9JYK92 HKEX Wholesale and retail trade
Open in API
Filings indexed 1,603 across all filing types
Latest filing 2026-05-07 Regulatory Filings
Country CN China
Listing HKEX 1099

About Sinopharm Group Co. Ltd.

http://www.sinopharmholding.com

Sinopharm Group Co. Ltd. is a major state-owned enterprise recognized as the largest pharmaceutical logistics provider in Asia and a leading distributor and retailer of healthcare products. The company's core business revolves around providing comprehensive medical supply chain services, encompassing the wholesale and retail distribution of pharmaceuticals, medical devices, and general healthcare products. Sinopharm serves a broad customer base, including hospitals, primary health service institutions, and retail pharmacies. Furthermore, the Group maintains an integrated ecosystem that extends beyond distribution into the manufacturing of pharmaceuticals and chemical reagents, medical services, and industry-finance integration, positioning it as a full-spectrum service provider in the healthcare sector.

Recent filings

Filing Released Lang Actions
Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 April 2026
Regulatory Filings Classification · 100% confidence The document is a monthly return filing (Form FF301) submitted to the Hong Kong Exchanges and Clearing Limited (HKEX) regarding movements in securities for Sinopharm Group Co. Ltd for the month ended 30 April 2026. It details movements in authorised/registered share capital, issued shares, treasury shares, and public float sufficiency confirmation. It is a regulatory compliance filing related to share capital and public float status, not a financial report, earnings release, or management discussion. It does not contain financial statements or management commentary but is a regulatory disclosure to the exchange. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory announcements that do not fit other specific categories.
2026-05-07 English
An announcement has just been published by the issuer in the Chinese section of this website, a corresponding version of which may or may not be published in this section
Report Publication Announcement Classification · 90% confidence The document is very short (under 5000 characters) and only states that an announcement has been published in another section of the website, without providing any substantive report or data. This matches the ‘Report Publication Announcement’ pattern (RPA) per the “menu vs meal” rule, as it merely notifies readers of a report’s availability rather than containing the report itself.
2026-04-29 English
ANNOUNCEMENT PRINCIPAL UNAUDITED ACCOUNTING DATA AND FINANCIAL INDICATORS OF SINOPHARM ACCORD FOR THE FIRST QUARTER ENDED 31 MARCH 2026
Interim / Quarterly Report Classification · 95% confidence The document is an announcement of principal unaudited accounting data and financial indicators for the first quarter ended 31 March 2026 of Sinopharm Accord, a subsidiary of Sinopharm Group Co. Ltd. It includes key financial metrics such as revenue, net profit, earnings per share, and return on equity, with comparative figures from the same period last year. The document references compliance with Hong Kong Stock Exchange listing rules and the Securities and Futures Ordinance. The content is focused on quarterly financial results with substantive financial data and analysis, indicating it is a comprehensive interim/quarterly report rather than a brief earnings release or a simple announcement. The length (5842 characters) and detailed financial data support classification as an Interim / Quarterly Report (IR).
2026-04-29 English
An announcement has just been published by the issuer in the Chinese section of this website, a corresponding version of which may or may not be published in this section
Report Publication Announcement Classification · 90% confidence The text is extremely short and simply states that an announcement has just been published in the Chinese section of the website. It does not contain substantive report content itself but only notifies readers of the report’s publication. Under the “menu vs meal” rule, this is an announcement of a report release rather than the report itself, fitting the definition of a Report Publication Announcement (RPA).
2026-04-27 English
ANNOUNCEMENT QUARTERLY FINANCIAL INFORMATION FOR THE THREE MONTHS ENDED 31 MARCH 2026
Interim / Quarterly Report Classification · 100% confidence The document is a formal announcement titled 'QUARTERLY FINANCIAL INFORMATION' for the three months ended 31 March 2026. It contains detailed consolidated financial statements (balance sheet, income statement, and cash flow statement) for both the Group and the Company. Since it provides substantive financial data for a period shorter than a full fiscal year, it is classified as an Interim/Quarterly Report (IR). Q1 2026
2026-04-27 English
An announcement has just been published by the issuer in the Chinese section of this website, a corresponding version of which may or may not be published in this section
Report Publication Announcement Classification · 92% confidence The text is extremely short (242 characters) and simply states that an announcement has been published elsewhere (“Listed Company Information”) without including actual report content. It’s an announcement of publication rather than the report itself. Therefore, it fits Report Publication Announcement (RPA).
2026-04-24 English

Browse filings by year

18 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.